Twist1 and the closely related twist2 (also known as dermo1 ) genes encode basic helixloop-helix transcription factors involved in the formation of mesoderm in Drosophila melanogaster ( 1 ) , cranial neural tube and limb morphogenesis in mice ( 2 ) , metastasis of tumor cells ( 3 ), control of apoptosis, and expression of cytokine genes in infl ammation ( 4, 5 ) . Mice deficient for twist2 or haploinsuffi cient for both twist1 and twist2 succumb to severe systemic T lymphocytes expressing the transgenic DO11.10 TCR specifi c for OVA were activated in vitro with splenic APCs and the cognate peptide OVA 327-339 under conditions that induce functional diff erentiation into Th1 cells, i.e., addition of IL-12 and blocking antibodies specifi c for IL-4. The transcriptional profi les of once-and four-time -stimulated Th1 cells were compared using high-density DNA microarrays. Among the 17 genes diff erentially expressed by a factor of two or more was twist1 . Expression of twist1 was up-regulated 38-fold in four-time -versus once-stimulated Th1 cells (Table S1 , available at http://www.jem.org/cgi/content/full/ jem.20072468/DC1).
Twist1 expression in Th1, but not Th2 or Th17, cells was confi rmed by real-time PCR ( Fig. 1 ) . Twist1 mRNA expression in resting Th1 cells correlated with their age in vitro and the number of restimulations they had experienced. Expression was further enhanced 3 h after polyclonal stimulation either with PMA and the Ca 2+ ionophore ionomycin, or with CD3-and CD28-specifi c antibodies ( Fig. 1 A ) . When determined 3 h after restimulation with anti-CD3/-CD28 antibodies, expression of twist1 was close to the detection limit in naive Th cells. Expression increased ‫ف‬ 15-fold during the fi rst Th1-polarizing stimulation, another 10-fold during the second stimulation, and another 3-fold during the third stimulation, reaching the maximum level after the fourth stimulation and remaining stable thereafter ( Fig. 1 A ) . With PMA/ionomycin restimulation, maximum levels of twist1 mRNA were reached after two rounds of stimulation. In Th1 cells, upon anti-CD3/-CD28 restimulation, twist1 mRNA expression was up-regulated within the fi rst hour, reaching maximum levels after 3 h, and decreasing again thereafter ( Fig. 1 B ) . Expression of twist1 mRNA was also detectable in restimulated Th2 cells, but its level remained 30-fold lower than in Th1 cells. In Th17 cells, the level of twist1 mRNA expression was even lower than in Th2 cells ( Fig. 1 C ) .
Twist1 protein was detectable in 6-d-old restimulated Th1 cells. In 24-d-old Th1 cells, expression was enhanced. In resting Th1 cells and in reactivated or resting Th2 cells, Twist1 was not detectable by immunoblotting ( Fig. 1 D ) . In agreement with the expression of twist1 mRNA, Twist1 protein expression peaked 3 h after reactivation, and then ceased, with levels still detectable 48 h after restimulation ( Fig. 1 E ) , but not at 6 d after restimulation.
Twist2 was not expressed in the Th1 and Th2 cells analyzed here, as determined by real-time PCR (unpublished data).
Control of twist1 expression in Th1 lymphocytes
The specifi c expression of twist1 by activated Th1 cells suggests that Th1-polarizing or Th1-specifi c signals are required for the induction of twist1 expression in Th cells. Indeed, IL-12/ STAT4 signaling induced twist1 expression in a dose-dependent fashion ( Fig. 2 A ) . IFN-␥ and STAT1 signaling did not induce twist1 expression in the absence of IL-12 ( Fig. 2 A ) . T-bet, a T box transcription factor suffi cient to induce Th1 diff erentiation ( 19 ) , is not required for induction of expression of twist1 ; induction of twist1 by IL-12 was comparable in T-bet -defi cient infl ammation, demonstrating the central role of Twist proteins in the regulation of infl ammation. Twist1 and twist2 are expressed by fi broblasts and macrophages, and expression is promoted by TNF-␣ and type I IFNs ( 4, 5 ) . The involvement of Twist expression by fi broblasts and macrophages in the control of infl ammation is probable, but has not been investigated in detail so far.
T helper 1 (Th1) lymphocytes are potent inducers of infl ammation. This has been demonstrated by adoptive transfer of Th1 lymphocytes in murine models of Th1-associated infl ammatory diseases such as diabetes ( 6 ) , infl ammatory bowel disease ( 7 ) , and rheumatoid arthritis ( 8 ) . In these models, the induction of infl ammation in a particular tissue by Th1 lymphocytes is dependent on restimulation by the cognate antigen in that tissue. Induction of infl ammation by Th1 cells is mediated by expression of the proinfl ammatory cytokines TNF-␣ and IFN-␥ , the latter being a hallmark of Th1 diff erentiation. IFN-␥ also induces expression of the chemokine receptor CXCR3 and its ligands CXCL9, -10, and -11, attracting Th1 cells specifi cally to infl amed tissue ( 9 ) . Th cells with the capacity to recall IFN-␥ expression, i.e., Th1 memory cells, are detectable in chronically infl amed tissue ( 10, 11 ) . The role of Th1 cells in the development and maintenance of chronic infl ammation is less clear. Anti -IFN-␥ therapy has been shown to be benefi cial in various Th1-associated infl ammatory diseases ( 12, 13 ) . However, a regulatory role for IFN-␥ has also been demonstrated, based on the induction of inducible nitric oxide synthase ( 14 ) and of IL-12 in antigenpresenting cells, in turn increasing the IL-10 synthesis of Th1 cells ( 15 ) . Furthermore, IFN-␥ inhibits the diff erentiation of naive Th cells into proinfl ammatory Th17 cells ( 16, 17 ) .
In this study, we demonstrate specifi c autoregulation of Th1 cells by the transcription factor twist1 . Expression of twist1 in Th cells is induced by IL-12/STAT4, NF-B, and NFAT, and thus is specifi c for Th1 cells. Th1 eff ector memory (EM) cells ( 18 ) show increased transient reexpression of twist1 upon T cell receptor engagement. Twist1 reduces the functionality of Th1 cells by attenuating expression of IL-2, TNF-␣ , and IFN-␥ . Th cells isolated from chronically infl amed gut tissue of patients with ulcerative colitis (UC) or Crohn ' s disease (CD) and synovial fl uid of patients with spondyloarthropathies or rheumatoid arthritis are imprinted to express high levels of twist1 , which indicates a history of repeated restimulation and an involvement in the pathogenesis of the disease. In murine models of acute and chronic infl ammation, i.e., delayed-type hypersensitivity (DTH) and antigeninduced arthritis, expression of twist1 by Th1 cells regulates Th1-mediated infl ammation.
RESULTS

Twist1 is transiently expressed in repeatedly activated
Th1 cells
To defi ne transcriptional changes during Th1 memory cell diff erentiation, we compared the global gene expression of murine Th1 cells, which were activated with antigen once or repeatedly at 6-d intervals. Naive CD4 + CD62L hi mouse revealed a conserved STAT binding site at position Ϫ 117 to Ϫ 137 ( Fig. 3 A ) . STAT4 did bind to the proximal promoter of twist1 in activated Th1 cells in the presence of IL-12 as shown by chromatin immunoprecipitation (ChIP; Fig. 2 D ) . and wild-type Th cells ( Fig. 2 B ) . Also, ectopically expressed T-bet did not induce twist1 expression in the absence of IL-12 in activated Th cells (Fig. S2 , available at http://www.jem .org/cgi/content/full/jem.20072468/DC1).
When CD4 + T lymphocytes of STAT4-defi cient mice were stimulated in the presence of IL-12 and IFN-␥ , no induction of twist1 expression was detectable ( Fig. 2 C ) . Phylogenetic comparison of the proximal promoter of twist1 from man and .org/cgi/content/full/jem.20072468/DC1), but also did not induce twist1 expression in activated Th2 cells, as described in Fig. 1 .
IL-12/STAT4 is required for the initial induction of twist1 expression and apparently imprints Th1 cells for reexpression of twist1 upon reactivation by antigen only. Upon restimulation of Th1 cells, cells cultured in the absence of IL-12 showed a 12-fold increase in the expression of twist1 , as compared with a 16-fold increase in the presence of IL-12 ( Fig. 2 E ) . IL-4/STAT6 signaling could not suppress twist1 expression in residual IFN-␥ -expressing cells of Th2 cultures (Fig. S3 , available at http://www.jem , colon (noninfl amed colon tissue), UC, and CD (endoscopic biopsies from UC and CD patients, respectively), RA, ReA, PsA, and AS (synovial fl uid from rheumatoid arthritis, reactive arthritis, psoriatic arthritis, and ankylosing spondylitis patients, respectively) with each dot representing one individual patient. Mean twist1 mRNA expression is displayed from patients who were repeatedly sampled.
as compared with Th2 cells (Fig. S4 , available at http://www .jem.org/cgi/content/full/jem.20072468/DC1).
Th cell -specifi c twist1 expression in vivo
The exclusive expression of twist1 in Th1 EM cells generated in vitro is refl ected by the expression pattern of twist1 in Th cells isolated ex vivo. Activated CD4 + CD62L hi naive and CD4 + CD62L lo memory cells isolated from the spleen and lymph nodes of healthy DO11.10 mice, kept under specifi c pathogen -free conditions, expressed low levels of twist1 ( Fig. 4 A ) . In CD4 + CD62L lo memory Th cells from lymph nodes of 4 -6-mo-old nephritic lupus-prone MRL/ lpr mice ( 23 ) twist1 mRNA was up-regulated by approximately twofold, as compared with CD4 + CD62L lo Th cells from DO11.10 spleen ( Fig. 4 A ) . Twist1 expression was enhanced by fi ve-to eightfold in CD3 + B220 + T cells from MRL/ lpr mice, which represent chronically activated T lymphocytes ( 24, 25 ) .
In analogy to murine Th lymphocytes, human Th cells can express twist1. Twist1 expression was enhanced by threefold in EM (i.e., CD45RA Ϫ CCR7 Ϫ ) Th cells, and eightfold in " terminally " diff erentiated CD27 Ϫ EM Th cells ( 26, 27 ) , whereas naive (CD45RA + CCR7 + ) and central memory (CM; i.e., CD45RA Ϫ CCR7 + ) Th lymphocytes expressed less twist1 than unseparated Th cells. Activated Th1 EM cells, characterized by the expression of CCR5 ( 28 ), expressed twist1 , whereas Th2 EM cells characterized by expression of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) ( 29 ) did not ( Fig. 4 
B ).
Because twist1 is expressed transiently upon activation of Th1 cells, we investigated whether signals from the TCR are involved in twist1 expression control. Phylogenetically conserved binding sites for the TCR signal transducers NF-B and NFAT are located in the twist1 promoter at positions Ϫ 104 to Ϫ 116 and Ϫ 129 to Ϫ 140 ( Fig. 3 A ) . The NF-B inhibitor pyrrolidine dithiocarbamate ( 20 ) , the NFAT-specifi c inhibitory 3,5-bistrifl uoromethyl pyrazole derivative BTP1 ( 21 ) , and the calcineurin-inhibitor cyclosporine A ( 22 ) all blocked the PMA/ionomycin-induced expression of twist1 mRNA ( Fig. 3 B ) , showing that both NFAT and NF-B are required for induction of twist1 expression in Th1 cells. Accordingly, stimulation with either TNF-␣ or PMA alone, both activating NF-B ( 20 ) but not NFAT, did not induce twist1 expression, whereas PMA in combination with the NFAT-activating ionomycin did ( Fig. 3 C ) .
Using ChIP, the specifi c binding of NFAT1 and the transactivating NF-B subunit p65 to the twist1 promoter of repeatedly stimulated Th1 cells was evident 1 h after reactivation ( Fig. 3 , D-E ). In Th2 cells, no activation-induced binding of NFAT1 or NF-B to the twist1 promoter was detectable, emphasizing that NFAT1 and NF-B are required, but not suffi cient, to induce transcription of twist1 in Th cells. For the initial expression of twist1 in Th1 cells, and its imprinting for reexpression in further restimulations, the concerted action of activated STAT4, NFAT1, and NF-B is required. Imprinting of the twist1 gene for reexpression in Th1 cells is refl ected by increased acetylation of histone H3 and trimethylated histone H3 at lysine 4, in both resting and reactivated Th1 cells, expressed twist1 transcript levels lower than the reference value of total peripheral Th cells (unpublished data).
Functional modulation of Th1 cells by twist1
We analyzed the impact of twist1 on the function of Th1 EM cells by ectopic overexpression of twist1 in murine DO11.10 Th cells. A global view of twist1 -induced modulation of gene expression in Th1 cells is provided in Fig. 5 . Of the 14,000 genes analyzed for transcription, 58 were diff erentially expressed by a factor of 1.5 or more when comparing activated Th1 cells that express twist1 ectopically and those that do not ( Fig. 5 ) . These genes fall into 4 groups, with respect to their presumptive function: 17 genes are involved in cell activation and apoptosis, 11 genes are involved in cell adhesion and motility, 13 genes relate to the chemokine/cytokine repertoire of Th1 cells, and 17 genes are of metabolic or undefi ned relevance.
Of relevance for the eff ector function of Th1 EM cells, twist1 attenuated expression of the eff ector cytokine genes il-2, ifn-␥ , and tnf-␣ by a factor of up to 1.6 ( Fig. 5 and Table S3 , available at http://www.jem.org/cgi/content/full/jem.20072468/DC1). The moderate reduction of mRNA levels of eff ector cytokines had a drastic eff ect on protein expression regardless of the direction of Th cell diff erentiation. Ectopic twist1 expression reduced the frequencies of cytokine-expressing reactivated Th1 or Th2, or of Th cells that had been stimulated without addition of polarizing cytokines to the culture, to 40 -50% of the controls ( Fig. 6 and Fig. S5 ).
The molecular basis of the regulation of cytokine gene expression by twist1 could be either direct inhibition of NF-B, as has been shown for COS cells ( 4 ), or binding of Twist1 to E-boxes of regulatory elements of the cytokine genes, blocking activating transcription factors, as has been shown for primary macrophages ( 5 ) . Here, we show that ectopic twist1 expression in activated Th cells cannot inhibit activation-induced transcription of an NF-B -reporter construct lacking E-boxes, i.e., Twist1 does not inhibit NF-B directly ( Fig. 7 A ) , in contrast to the constitutively active mutant form of inhibitor of NF-B ( I-B ␣ M ), in an experimental situation where both Twist1 and I-B ␣ M are expressed at similar levels (Fig. S6 , available at http://www.jem.org/cgi/ content/full/jem.20072468/DC1), and both attenuate the expression of endogenous cytokine genes to the same degree ( Fig. 7 B ) . This result implies that twist1 regulates gene expression of Th1 cells by binding to E-boxes of specifi c target genes, and not the entirety of NF-B -regulated genes. NF-B signaling for the generation and survival of Th1 memory cells ( 30, 31 ) is not inhibited by twist1 , as is also evident from the high twist1 expression of repeatedly restimulated Th1 cells ( Fig. 1 ).
Twist1 regulates Th1-mediated infl ammation
In a murine transfer model of OVA-specifi c DTH, the eff ect of twist1 expression on the infl ammation induced by transferred Th1 cells was analyzed. OVA-specifi c 6-d-old Th1 cells ectopically overexpressing twist1 and control Th1 cells were transferred intravenously into naive BALB/c mice.
Th cells isolated from infl amed tissue of patients with chronic infl ammatory diseases are imprinted for high twist1 expression. Although highly variable, twist1 transcripts were increased by up to 400-fold, as compared with peripheral Th cells, in CD3 + CD4 + cells isolated from the synovial fl uid of infl amed joints of patients with rheumatoid arthritis or spondyloarthropathies, and in Th cells isolated from mucosal endoscopic biopsies and surgical specimens of patients suff ering from CD or UC ( Fig. 4 C and Table S2 , available at http://www.jem .org/cgi/content/full/jem.20072468/DC1). Twist1 mRNA expression in repeatedly sampled patients with persistent infl ammation of colon or synovia remained in the same range over up to 18 mo (Table S2 ). Among T cells isolated from the infl amed tissue, only CD4 + Th cells showed enhanced twist1 expression. CD3 + CD4 Ϫ cells, i.e., cytotoxic (Tc) lymphocytes, ized OVA into the knee joint, and histological analysis was performed 3 wk after induction of arthritis, i.e., in the chronic phase of infl ammation. Twist1 knockdown and control Th1 cells equally homed to and persisted in the spleen and mesenteric and draining lymph nodes ( Fig. 9, C -E ) . However, twist1 knockdown in Th1 cells resulted in a signifi cantly higher histological score of infl ammation and tissue destruction ( Fig. 9 F and Table S4 , available at http://www.jem.org/cgi/content/ full/jem.20072468/DC1). In particular, infi ltration of granulocytes and mononuclear cells into the infl amed tissue of the knee joint was drastically enhanced ( Fig. 10 and Fig. S8 ), as were characteristics of chronic infl ammation, i.e., prominent hyperplasia of the lining cells, pannus formation, increased vascularization, and hyperplasia of synovial fi broblasts in the sublining layer ( Fig. 10 and Fig. S8 ). Increased numbers of Gr-1 + granulocytes at the surface of the synovium and focal accumulation of F4/80 + macrophages were observed after transfer of twist1 knockdown Th1 cells as compared with control Th1 cells (Fig. S8) . Anti-TNF-␣ staining of joint sections revealed stronger TNF-␣ expression, especially in the lining cells and the sublining layer after transfer of Th1 cells expressing a twist1 -targeting shRNA ( Fig. 10 ) . Presumably as an additional consequence of the higher infl ammation in the mice receiving twist1 knockdown Th1 cells, more CD3 + T cells were found in the infl amed joints ( Fig. 10 ) .
DISCUSSION
Control of infl ammation critically depends on the twist genes. Genetic haploinsuffi ciency of both twist1 and twist2 results in fatal systemic infl ammatory immunopathology in mice, which die before day 14 ( 4 ) . In this study, we show that twist1 is expressed in Th1 EM cells. Its expression is induced by IL-12 After 1 d, OVA 323-339 emulsifi ed in IFA was injected into one footpad and the swelling of this footpad was monitored. Th1 cells overexpressing twist1 showed a signifi cantly (P < 0.05) reduced induction of footpad swelling, starting from day 4 to 7, when compared with control Th1 cells ( Fig. 8 A ) . For DTH mediated by Th1 cells the proinfl ammatory role of Th1-derived cytokines such as IFN-␥ has been shown ( 32 ) . Transferred Th cells overexpressing twist1 , when reisolated from the draining lymph nodes of the host, expressed fourfold reduced levels of IFN-␥ mRNA as compared with the control cells ( Fig. 8 B ) . Homing of transferred Th1 cell populations to the infl amed tissue and the draining lymph nodes was not aff ected by twist1 overexpression, as shown by the transfer of radiolabeled cells ( Fig. 8 C ) . The accumulation of ectopically twist1-expressing Th1 cells in the draining lymph nodes and the infl amed foot pads, as well as in other organs (Fig. S7 , available at http://www.jem.org/cgi/content/full/ jem.20072468/DC1), was comparable to that of transferred control Th1 cells.
Autoregulation of Th1-mediated infl ammation by twist1 was also analyzed in a murine adoptive transfer model of antigeninduced arthritis ( Fig. 9 A ) . In this model, we used the complementary genetic approach to knockdown twist1 expression in Th1 cells by RNA interference. Murine DO11.10 Th1 cells generated in vitro were infected with a retrovirus encoding a small hairpin RNA (shRNA) targeting twist1 ( 3 ) or a corresponding scrambled control shRNA. Twist1 -specifi c shRNA reduced the level of activation-induced endogenous twist1 transcripts in Th1 cells to ‫ف‬ 30% of the control value ( Fig. 9 B ) . Two-time restimulated Th1 cells expressing those shRNAs were intravenously injected into SCID mice. 1 d after cell transfer, arthritis was induced by injection of cation- only in the original stimulation, to imprint the gene for reexpression. This imprinting is evident from the increased reexpression upon stimulation with TCR signals alone, in the absence of IL-12, and it is refl ected in the acetylation and trimethylation of H3 histones at the twist1 promoter region, as is shown here. The requirement of NFAT for induction of twist1 expression in Th1 cells distinguishes control of twist1 expression in Th cells from its control in fi broblasts, where TNF-␣ -induced activation of NF-B is suffi cient to induce expression ( 4 ). In activated macrophages, type I IFNs induce the expression of twist1 ( 5 ), and they express both twist genes, i.e., twist1 and twist2 , whereas activated Th1 cells exclusively express twist1. In Th lymphocytes, twist1 expression is not induced by type I IFNs. Addition of IFN-␣ during the primary activation of Th cells in the absence of IL-12 did not suffi ce to induce twist1 expression (Fig. S9 , available at http://www.jem.org/cgi/content/full/jem.20072468/DC1). via STAT4 and TCR signaling, activating NFAT and NF-B. Expression of twist1 follows TCR stimulation transiently and increases upon repeated stimulation. Thus, imprinting for enhanced twist1 expression is a hallmark of repeatedly restimulated Th1 memory cells.
The proximal promoter of twist1 contains phylogenetically conserved binding sites for NFAT, NF-B, and STAT proteins. Both NFAT and NF-B have to bind to the promoter of twist1 in Th cells to induce expression, i.e., twist1 is expressed only by activated Th cells. In the initial activation of naive Th cells, NFAT and NF-B cannot induce transcription of twist1 on their own, but require concerted binding of activated STAT4 to the promoter of twist1 . Of all costimulatory signals involved in the lineage diff erentiation of murine Th1, Th2, or Th17 cells, only IL-12 was able to induce transcription of twist1 . Neither IL-4, in Th2 polarization, nor IL-6, TGF-␤ , and IL-23 in Th17 polarization, could induce expression of twist1 . Of the Th1-polarizing signals, IL-12/STAT4, but not IFN-␥ /STAT1, is required to induce twist1 expression. T-bet is not involved. STAT4 is required to a subset of memory cells. Among murine CD4 + CD62L lo memory-phenotype Th cells that were isolated from spleen or lymph nodes of naive DO11.10 mice, expression of twist1 is low. In CD3 + B220 + T cells isolated from nephritic MRL/ lpr mice, which represent chronically activated T cells ( 24, 25 ) , twist1 expression is up-regulated fi ve-to eightfold compared with DO11.10 memory-phenotype Th cells. This is moderate when compared with the ‫ف‬ 20-fold up-regulation upon repeated restimulation of Th1 cells observed in vitro, and may refl ect the heterogeneous composition of the cell populations analyzed. As expected from the phylogenetic conservation of the twist1 promoter, twist1 is also expressed by activated human Th cells. It is low in peripheral human naive Th cells and in CCR7 + CM Th cells. Twist1 expression is enhanced in CCR7 Ϫ EM Th cells, in particular in the " terminally diff erentiated " CCR7 Ϫ CD27 Ϫ EM cells ( 26, 27 ) . Among CCR7 Ϫ EM cells, twist1 is expressed less by CRTh2 + Th cells, which have been shown to be mostly Th2 cells ( 29 ) . CCR7 Ϫ CCR5 + EM cells, which contain Th1 EM and Th17 EM cells ( 33 ) have up-regulated activation-induced expression of twist1 , as we show here. Because at least Th17 cells generated in vitro do not express twist1 , the expression in CCR7 Ϫ CCR5 + Th EM cells is probably caused by Th1 EM cells. Thus, the phenotype of human peripheral twist1 -expressing Th cells is that of repeatedly restimulated Th1 EM cells. Remarkably, expression of twist1 is highly up-regulated in CD3 + CD4 + T cells isolated from infl amed tissues of patients with chronic infl ammation of joints or gut. Repeated biopsies from individual patients show persistent twist1 mRNA levels over time, i.e., the persistence of chronically reactivated Th1 cells, despite state-ofthe-art therapeutic treatment. Their imprinting for increased twist1 expression, maintained over time in individual patients, indicates a history of repeated restimulation and an endogenous regulation of proinfl ammatory eff ector functions under the control of NFAT and NF-B.
Twist1 itself is a transcriptional repressor binding to Eboxes in the regulatory regions of target genes ( 34 ) . For COS cells, it has been shown that ectopically expressed twist1 can interact directly with the p65 subunit of NF-B and inhibit its function ( 4 ). In contrast, for primary murine macrophages, twist1 has been shown to block transcription of target genes by binding to E-boxes within the promoter ( 5 ) . In this study, we show that in Th1 cells, twist1 cannot block NF-B -driven transcription of a reporter gene construct that lacks E-boxes in the promoter, suggesting that twist1 acts through binding to E-boxes, as in macrophages. In accordance, ectopically expressed twist1 only regulates the expression of a restricted set of 58 genes in 1-wk-old Th1 cells by a factor of at least 1.5. Expression of 29 genes is up-regulated, and that of another 29 genes down-regulated. Apart from several genes of unknown and metabolic function, these genes are involved in survival, eff ector function, and motility of the cells. With respect to cytokine expression, twist1 reduces activation-induced expression of TNF-␣ , IL-2, and IFN-␥ by Th1 memory cells by > 50% at the protein level. Apart from cytokine expression, twist1 also decreases expression of proinfl ammatory chemokines These fi ndings provide evidence that expression of the antiinfl ammatory twist genes is controlled by type I IFNs and TNF-␣ in fi broblasts and macrophages in innate immune responses ( 4, 5 ) , and is controlled by antigen and IL-12 in Th cells in adaptive immune responses; i.e., twist expression is induced by those cytokines controlling the induction of infl ammatory immune responses.
In this study, we have identifi ed twist1 as a gene that is diff erentially expressed by Th1 cells versus Th2 cells, comparing the transcriptomes of once and repeatedly restimulated murine Th1 and Th2 cells generated in vitro from bona fi de naive Th cells. Expression of twist1 increases upon repeated restimulation in vitro in Th1 cells, whereas it is not induced even in repeatedly restimulated Th2 or Th17 cells. Accordingly, in Th cells isolated ex vivo, twist1 expression is restricted Th cells, by means of either addressing twist1 or a gene regulated by it, seems more promising, because it is more specifi c for repeatedly restimulated Th1 memory cells involved in chronic infl ammation. It remains to be shown whether these cells in chronic infl ammatory diseases are the critical Th cells capable of driving infl ammation, as we show in this study for the experimental model of antigen-induced arthritis.
MATERIALS AND METHODS
Mice and reagents. MRL lpr/lpr , BALB/c, C57BL/6, SCID, STAT4-deficient mice (Stat4 tm1Gr ), and OVA-TCR tg/tg DO11.10 mice were purchased from The Jackson Laboratory or were bred under specifi c pathogen -free conditions in our animal facility. T-bet -defi cient mice were a gift from J. Penninger (Institute for Molecular Biotechnology of the Austria Academy of Sciences, Vienna, Austria). All animal experiments were performed in accordance with institutional, state, and federal guidelines (Landesamt F ü r Gesundheit und Soziales, Berlin, Germany). Reagents were purchased from Sigma-Aldrich unless otherwise stated. BTP1 was synthesized by M. Paetzel (Humboldt University of Berlin, Berlin, Germany). Cyclosporin A was purchased from Calbiochem.
Patients. Endoscopic mucosal and surgical mucosal specimens were obtained from UC ( n = 9) and CD ( n = 7) patients. UC and CD were diagnosed according to established clinical, endoscopic, radiological, and pathological criteria. All UC and CD patients displayed moderately to severely active disease according to the Truelove and Witts Severity Index ( 41 ) and the Harvey Bradshaw Severity Index ( 42 ), respectively. Control samples were obtained from patients ( n = 4) undergoing colonectomy because of colon cancer. Mucosal control specimens used in the study were from the macroscopically noninvolved tissue distant from any detectable lesion. Synovial fl uid was obtained from patients suff ering from rheumatic diseases who had active synovitis with eff usion. Patients with rheumatoid arthritis (RA; n = 4) fulfi lled the American College of Rheumatology 1987 classifi cation criteria for RA, patients with ankylosing spondylitis (AS; n = 5) fulfi lled the modifi ed New York criteria (1984), and patients with psoriatic arthritis ( n = 3) or reactive arthritis ( n = 3) fulfi lled the European Spondyloarthropathy Study Group (ESSG) criteria for SpA. Clinical characteristics of the patients are listed in Table S2 . All experiments were approved by the local ethics committee (Charite Ethikkommision), and all patients gave informed consent.
Isolation of human lymphocytes. PBMCs from buff y coats from healthy donors, and synovial fl uid mononuclear cells were isolated by density gradient centrifugation (Lymphocyte separation medium; PAA). Pooled intraepithelial leukocytes and lamina propria leukocytes were obtained from mucosal specimens by treatment with collagenase type IV, followed by passage through a sieve. Mononuclear cells were collected from the 40 -70% interphase of a discontinuous percoll (Pharmacia) gradient.
Flow cytometry. The following antibodies directed against murine antigens were either purifi ed from hybridoma supernatants and conjugated inhouse or purchased as indicated: anti-CD3 (145-2C11), anti-CD4 (GK1.5), anti-CD8 (53 -6.7), anti-CD11c (N418), anti-CD44 (IM7), anti-CD62L (MEL14), anti-DO11.10 OVA-TCR (KJ1.26), anti-B220 (RA3.6B2), anti-IL2 (JES6-5H4; Caltag Laboratories), anti-IL-4 (11B11; BD Biosciences), anti-IFN-␥ (AN18.17.24), and anti-TNF-␣ (MP6-XT22; Caltag). Antibodies recognizing human antigens were obtained from BD Biosciences unless stated otherwise: anti-CD3 (OKT3; in-house conjugate), anti-CD4 (TT1; in-house conjugate), anti-CD27 (L128), anti-CD45RA (HI100), anti-CRTh2 (BM16), and anti-CCR5 (2D7/CCR5). Cells were counted by using FlowCount Beads (Beckman Coulter). Cytometric analysis was performed with FACSCalibur using CellQuest (BD Biosciences) and FCS Express (De Novo) software. Cells were separated by fl uorescence-activated cell sorting (FACSAria and FACSDiva; BD Biosciences). Why is expression of twist1 up-regulated gradually? One explanation might be that a regulatory gene is not expressed in initial Th1 activations, to allow full initial reactivity of the Th1 cells. Accordingly, ectopic twist1 expression in Th1 cells right from the beginning impairs their function in acute infl ammation of DTH. In repeated restimulations, refl ecting a lack of clearance of the antigen and increased risk of immunopathology, regulation of Th1 may help to limit immunopathology, as we show in the chronic infl ammation of the antigeninduced arthritis model by knockdown of twist1 , but twist1 -expressing Th1 cells are still capable of driving infl ammation.
Apart from its role in limiting immunopathology in chronic infl ammation, twist1 and the genes controlled by it could be regarded as biomarkers for pathogenic EM cells. Twist1 is not imprinted for enhanced expression in naive and CM CCR7 + Th cells. Even CCR7 Ϫ CCR5 + Th1 EM cells will only express a low level of twist1 upon restimulation compared with Th cells from chronically infl amed tissue. Initial clinical studies aiming at a complete depletion of CD4 + T lymphocytes in patients with chronic infl ammatory diseases suggested a clinical benefi t, but the studies had to be terminated because of the severe side eff ects of systemic depletion of Th lymphocytes ( 35 -37 ) . Targeting of CD4-and CD3-expressing cells with nondepleting antibodies and neutralization of Th-related eff ector cytokines have demonstrated clinical effi cacy ( 12, 13, 15, 38 -40 ) , but all of them impair protective as well as pathogenic T cell memory. Targeting of twist1 -expressing or F4/80 (eBioscience). For detection biotinylated donkey anti -rat or donkey anti -goat (Dianova) secondary antibodies were used followed by the streptavidin AP kit (K5005; Dako). Or sections were incubated with goat anti-TNF-␣ antibody followed by Alexa Fluor 555-conjugated anti -goat antibody (Invitrogen) and incubated with rabbit polyclonal anti-CD3 followed by Alexa Fluor 488 -conjugated anti -rabbit antibody (Invitrogen). Nuclei were counterstained with DAPI (Roche), and slides were mounted in Fluoromount-G (SouthernBiotech). Images were acquired using a fl uorescence microscope (AxioImager Z1) equipped with a charge-coupled device camera (AxioCam MRm) and processed with Axiovision software (Carl Zeiss, Inc.).
Luciferase reporter assay. NF-B activity was monitored using the pNF-B-Luc vector (Clontech Laboratories, Inc.). Transfection effi ciency was controlled by cotransfecting pRL-TK (Promega). Murine T cells were electroporated with the reporter constructs using Mouse T cell kit (AMAXA) and Nucleofector I (AMAXA). Luciferase activity was quantifi ed with Dual Luciferase Assay kit (Promega) and a luminometer (Moonlight 3096; BD Biosciences).
Microarray experiments. Total RNA was extracted using Trizol reagent (Invitrogen), 10 μ g was reverse-transcribed, followed by cDNA extraction with a PhaseLock gel (Eppendorf), and precipitated with ethanol and ammonium acetate. Biotinylated cRNA was transcribed with the MEGAscript high-yield transcription kit (Ambion), fragmented, and the hybridization cocktail was prepared according to Aff ymetrix protocols (15 μ g fragmented biotin-labeled cRNA spiked with Eukaryotic Hybridization control). The Cell culture. Naive CD4 + CD62L + lymphocytes from 6 -8-wk-old DO11.10 mice were isolated and polarized under Th1 or Th2 conditions, as previously described ( 15 ) . Irradiated (30 Gy) BALB/c splenocytes were used as APCs at a ratio of 5:1 and the cognate peptide OVA 323-339 (provided by R. VolkmerEngert, Humboldt University of Berlin, Berlin, Germany) was added at 0.5 μ M. Alternatively, plates were coated with 3 μ g/ml anti-CD3 (145-2C11) in PBS, and CD4 + cells were plated at a density of 2 × 10 6 cells/ml in medium plus 1 μ g/ml soluble anti-CD28 ( Mitogenic restimulation and intracellular cytokine staining. Cells were restimulated with 10 ng/ml PMA, and 1 μ g/ml ionomycin or with plate-bound anti-CD3 (10 μ g/ml), and soluble anti-CD28 (1 μ g/ml). For restimulation of murine T cells, 10 ng/ml IL-2 was added. For intracellular staining of cytokines, T cells were stimulated for 2 h with PMA/ionomycin and an additional 3 h with 5 μ g/ml of brefeldin A. Cells were fi xed with 2% formaldehyde in PBS for 15 min at room temperature and permeabilized with 0.5% wt/vol saponin.
ChIP. ChIP was performed as previously described ( 15 ) Th1-mediated DTH model. The OVA-specifi c DTH model was performed as described elsewhere ( 43 ) . In brief, 5 × 10 5 Th1 cells were injected i.v. into BALB/c mice, and 24 h later, the DTH response was induced by s.c. injection of 250 ng OVA 323-339 /IFA into the left footpad. PBS/IFA, injected into the right footpad, served as a control. The footpad thickness measured before the injection of the antigen was subtracted from the footpad thickness measured during the DTH response. The homing of adoptively transferred Th1 cells was performed as previously described ( 44 ) . In brief, Th cells were labeled with 51 Chromium (Amersham Buchler) at 37 ° C (2 × 10 7 cells/ml; 20 μ Ci/ml) in fresh medium. Removal of dead cells was done by gradient centrifugation (17.1% isotonic Nycodenz). Labeled cells were coadoptively transferred into recipient animals at 1 d after the DTH induction. 24 h later, indicated tissues were removed and diff erential measurement of recovered radioactivity was done on a ␥ counter (Wallac Counter).
Antigen-induced arthritis. 2 × 10 6 12-d-old GFP + Th1 cells were transferred i.v. into naive SCID mice. 1 d later, arthritis was induced by intraarticular injection of 60 μ g cationized OVA into one knee joint. The contralateral knee joint was left untreated. 21 d later, mice were killed and knee joints were fi xed in 10% formaldehyde, decalcifi ed in saturated EDTA solution, and embedded in paraffi n. Knee joint sections were stained with hematoxylin/eosin and scored for exudates, granulocyte infi ltration, hyperplasia, fi broblast proliferation/mononuclear cell infi ltration, periarticular mononuclear cell infi ltration (each scoring 0 -3), bone/cartilage destruction (scoring 0 -4), and an additional score of 1 for visible fi brin deposition and periarticular granulocyte infi ltration, resulting in a maximum score of 21.
Immunohistochemistry. Formalin-fi xed paraffi n-embedded tissue was subjected to a heat-induced epitope retrieval step and stained with anti-CD3 (#N1580; Dako), TNF-␣ (PeproTech), anti-Gr-1 (RB6-8C5; eBioscience), Murine Genome U74A version 2, and 430A version 2 GeneChip arrays (Aff ymetrix) were hybridized at 45 ° C for 16 h, stained with streptavidinphycoerythrin using the Aff ymetrix GeneChip Fluidics Workstation 400, and scanned on a Hewlett-Packard Gene Array Scanner (MGU74Av2 arrays) or on an Aff ymetrix GeneChip Scanner 3000 (MG430Av2 arrays). Data were analyzed using the Microarray Suite 5.0 software (Aff ymetrix). Microarrays were globally normalized and scaled to a trimmed mean expression value of 200. All arrays were compared with each other, and a relational database was generated using Microsoft Access software, including the following parameters: expression heights, call for presence of transcripts, P value for presence or absence of transcripts, log 2 value of fold change and 95% confi dence intervals, call for the signifi cance of diff erentially expression, and the P value for that call. For each transcript the signifi cance of diff erential expression between the groups of arrays was calculated using strict Bonferroni-corrected Welch t tests. Signifi cantly diff erentially expressed genes were fi ltered according to the following criteria: mean fold change ≥ 2 or ≥ 1.5; diff erence of means ≥ 200; P value ≤ 0.05; and immunoglobulin genes were excluded. Data are deposited at http://www.ncbi.nlm.nih.gov/geo/ (AccessionID SuperSeries: GSE11556).
Real-time PCR. Real-time PCR was performed as previously described ( 15 ) . For normalization of murine and human cDNA the transcripts for the housekeeping genes hypoxanthine guanine phosphoribosyl transferase and ubiquitin ligase H5 (UbcH5) were quantifi ed, respectively. Relative expression was calculated as follows: E t Δ Cp target gene (reference -sample) / E h Δ Cp housekeeping gene (reference -sample) , where Cp represents the crossing point and E represents the reaction effi ciency, determined by serial dilution of DNA. Primer sequences are listed in Table S5 (available at http://www.jem .org/cgi/content/full/jem.20072468/DC1).
In silico genomic DNA analysis. The genomic sequences for the twist1 locus of Mus musculus and Homo sapiens were obtained from UCSC Genome Bioinformatics (http://genome.ucsc.edu) and submitted to Matinspector analysis at http://www.genomatix.de/matinspector.html.
Statistics. Statistical signifi cance in animal models (DTH and antigeninduced arthritis) was calculated using the two-tailed Mann -Whitney test (*, P < 0.05; **, P < 0.01; ***, P < 0.005).
Online supplemental material. Fig. S1 shows representative cytokine profi les of ex vivo -polarized Th1, Th2, and Th17 cells. Fig. S2 displays the result of ectopic T-bet expression on twist1 mRNA induction, as well as an immunoblot to confi rm T-bet overexpression. Fig. S3 shows cytokine data and mRNA profi les of cells cultured in the simultaneous presence of IL-12 and IL-4 compared with Th1 cells. The ChIP for acetylated and trimethylated histone 3 binding to the twist1 promoter are shown in Fig. S4 . The dot plots comparing cytokine expression in twist1 overexpressing and control Th cells are shown in Fig. S5 . Immunoblots confi rming comparable protein expression levels of Twist1 and I B-␣ M upon retroviral overexpression are shown in Fig. S6 . Fig. S7 displays in vivo migration capacity of twist1 overexpressing and control Th1 cells to remaining organs despite footpad and draining lymph nodes in the DTH response. Fig. S8 shows additional immunohistochemical stainings of the infl ammatory response in murine arthritis. In Fig. S9 , the eff ect of type I IFNs on twist1 induction is shown. Genes diff erentially expressed in once-versus four-time -stimulated Th1 cells are shown in Table S1 . Clinical characteristics of patients in the study are listed in Table S2 . Genes diff erentially expressed upon ectopic twist1 overexpression are listed in Table S3 . Table S4 shows detailed results of the histological scoring in murine arthritis. Table S5 shows primer sequences. The online version of this article is available at http://www.jem .org/cgi/content/full/jem.20072468/DC1. 
